Bruce Levine, PhD
University of Pennsylvania
Philadelphia, PA, United States

[1] Caplan A, Levine B. Hope, hype and help: ethically assessing the growing market in stem cell therapies. American Journal of Bioethics 2010; 10(5):24-5. https://doi.org/10.1080/15265161.2010.481980

[2] Gunter KC, Caplan AL, Mason C, Salzman R, Janssen WE, Nichols K, Bouzas LF, Lanza F, Levine BL, Rasko JE, Shimosaka A, Horwitz E: Cell therapy medical tourism: time for action. Cytotherapy 2010; 12(8): 965-8. https://doi.org/10.3109/14653249.2010.532663

[3] Keeping patients safe from unproven cell therapies: an interview with the ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell and Gene Therapies. RegMedNet February 2019. https://www.regmednet.com/channels/195-ethics-policy/posts/